The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Eastman Chemical Co

NYSE: EMN
Last

(U.S.) $60.66

Today's change+2.22 +3.80%
Updated February 12 4:04 PM EST. Delayed by at least 15 minutes.
 

Eastman Chemical Co

NYSE: EMN
Last

(U.S.) $60.66

Today's change+2.22 +3.80%
Updated February 12 4:04 PM EST. Delayed by at least 15 minutes.

Eastman Chemical Co up sharply

Eastman Chemical Co closed up sharply Friday, rallying (U.S.)$2.22 or 3.80% to (U.S.)$60.66. Over the last five days, shares have gained 0.45%, but are down 10.15% for the last year to date. Shares have underperformed the S&P 500 by 8.53% during the last year.

Key company metrics

  • Open(U.S.) $58.87
  • Previous close(U.S.) $58.44
  • High(U.S.) $60.82
  • Low(U.S.) $58.00
  • Bid / Ask-- / --
  • YTD % change-10.15%
  • Volume1,827,487
  • Average volume (10-day)2,307,322
  • Average volume (1-month)1,657,595
  • Average volume (3-month)1,374,309
  • 52-week range(U.S.) $56.03 to (U.S.) $83.90
  • Beta1.64
  • Trailing P/E10.71×
  • P/E 1 year forward8.34×
  • Forward PEG1.44×
  • Indicated annual dividend(U.S.) $1.84
  • Dividend yield3.03%
  • Trailing EPS(U.S.) $5.66
Updated February 12 4:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.85%

Based on its net profit margin of 8.85%, Eastman Chemical Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:Basic MaterialsIndustry:Chemicals - Commodity
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue2,2252,4472,5332,443
Total other revenue--------
Total revenue2,2252,4472,5332,443
Gross profit509695720656
Total cost of revenue1,7161,7521,8131,787
Total operating expense2,0532,0152,0642,132
Selling / general / administrative210178194180
Research & development74645756
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)53210109
Other operating expenses, total--------
Operating income172432469311
Interest income (expense), net non-operating---71-72-72
Gain (loss) on sale of assets--------
Other--------
Income before tax117353403256
Income after tax125258299172
Income tax, total-89510484
Net income124256297171
Total adjustments to net income--------
Net income before extra. items124256297171
Minority interest-1-2-2-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items124256297171
Inc. avail. to common incl. extra. items124256297171
Diluted net income124256297171
Dilution adjustment--------
Diluted weighted average shares150150150150
Diluted EPS excluding extraordinary itemsvalue per share0.831.711.981.14
Dividends per sharevalue per share0.400.400.400.40
Diluted normalized EPSvalue per share1.061.681.951.70